Christopher Neyor

Stock Analyst at JP Morgan

(1.66)

# 2,192

Out of 4,433 analysts

3

Total ratings

50%

Success rate

37.42%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KALA Kala Pharmaceuticals	Downgrades: Underweight	$75	$6.73	+1,014.41%	2	Mar 30, 2022
	PCRX Pacira BioSciences	Upgrades: Overweight	n/a	$31.51	-	1	Jul 26, 2021

Kala Pharmaceuticals

Mar 30, 2022

Downgrades: Underweight

Price Target: $75

Current: $6.73

Upside: +1,014.41%

Pacira BioSciences

Jul 26, 2021

Upgrades: Overweight

Price Target: n/a

Current: $31.51

Upside: -